Price $60.20 |
Market Cap
669.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
44.2
|
P/B
3.71
|
P/S
1.55
|
Dividend %
-
|
|
P/CF
15.3
|
P/FCF
12.4
|
Op. Cash Flow
57.4K
|
FCF
4.6
|
|
Op. Margin
5.50%
|
Net Margin
3.30%
|
ROE
8.20%
|
ROI
8.70%
|
|
ROA
5.30%
|
EPS Growth
-11.90%
|
Current Ratio
2.9
|
Debt/Equity
22.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Valeant Pharmaceuticals Intl I (VRX) | $24.27 | - | - | 7.68B | Strong Buy |
| Nature's Sunshine Prod. (NATR) | $9.25 | - | 4.40% | 172.5M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $23.99 | - | 3.90% | 22.05B | Strong Buy |
| NeoGenomics, Inc. (NEO) | $14.05 | - | - | 935.2M | Strong Buy |
| Neurometrix Inc (NURO) | $1.33 | - | - | 10M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
